168 related articles for article (PubMed ID: 15016741)
1. Intestinal B cell hyperactivity in AIDS is controlled by highly active antiretroviral therapy.
Nilssen DE; Øktedalen O; Brandtzaeg P
Gut; 2004 Apr; 53(4):487-93. PubMed ID: 15016741
[TBL] [Abstract][Full Text] [Related]
2. Elevated mucosal addressin cell adhesion molecule-1 expression in acquired immunodeficiency syndrome is maintained during antiretroviral therapy by intestinal pathogens and coincides with increased duodenal CD4 T cell densities.
Miao YM; Hayes PJ; Gotch FM; Barrett MC; Francis ND; Gazzard BG
J Infect Dis; 2002 Apr; 185(8):1043-50. PubMed ID: 11930313
[TBL] [Abstract][Full Text] [Related]
3. B-cell activation in duodenal mucosa after oral cholera vaccination in IgA deficient subjects with or without IgG subclass deficiency.
Nilssen DE; Friman V; Theman K; Björkander J; Kilander A; Holmgren J; Hanson LA; Brandtzaeg P
Scand J Immunol; 1993 Aug; 38(2):201-8. PubMed ID: 8346420
[TBL] [Abstract][Full Text] [Related]
4. Intraepithelial γδ T cells remain increased in the duodenum of AIDS patients despite antiretroviral treatment.
Nilssen DE; Brandtzaeg P
PLoS One; 2012; 7(1):e29066. PubMed ID: 22238587
[TBL] [Abstract][Full Text] [Related]
5. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
[TBL] [Abstract][Full Text] [Related]
6. Rapid increase of mucosal CD4 T cells followed by clearance of intestinal cryptosporidiosis in an AIDS patient receiving highly active antiretroviral therapy.
Schmidt W; Wahnschaffe U; Schäfer M; Zippel T; Arvand M; Meyerhans A; Riecken EO; Ullrich R
Gastroenterology; 2001 Mar; 120(4):984-7. PubMed ID: 11231952
[TBL] [Abstract][Full Text] [Related]
7. Intestinal IgA- and IgM-producing cells are not decreased in marathon runners.
Nilssen DE; Oktedalen O; Lygren I; Opstad PK; Brandtzaeg P
Int J Sports Med; 1998 Aug; 19(6):425-31. PubMed ID: 9774211
[TBL] [Abstract][Full Text] [Related]
8. Increased immunoglobulin G production by short term cultured duodenal biopsy samples from HIV infected patients.
Schneider T; Zippel T; Schmidt W; Pauli G; Wahnschaffe U; Chakravarti S; Heise W; Riecken EO; Zeitz M; Ullrich R
Gut; 1998 Mar; 42(3):357-61. PubMed ID: 9577341
[TBL] [Abstract][Full Text] [Related]
9. Persistent T cell and B cell activities in the duodenal mucosa of AIDS patients.
Carol M; Lambrechts A; Urbain D; van Vooren JP; Clumeck N; Goldman M; Mascart-Lemone F
AIDS; 1998 Oct; 12(14):1763-9. PubMed ID: 9792376
[TBL] [Abstract][Full Text] [Related]
10. Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients.
Zhang ZN; Shang H; Jiang YJ; Liu J; Dai D; Diao YY; Geng WQ; Jin X; Wang YN
Chin Med J (Engl); 2006 Dec; 119(23):1966-71. PubMed ID: 17199940
[TBL] [Abstract][Full Text] [Related]
11. Loss of CD4 T lymphocytes in patients infected with human immunodeficiency virus type 1 is more pronounced in the duodenal mucosa than in the peripheral blood. Berlin Diarrhea/Wasting Syndrome Study Group.
Schneider T; Jahn HU; Schmidt W; Riecken EO; Zeitz M; Ullrich R
Gut; 1995 Oct; 37(4):524-9. PubMed ID: 7489940
[TBL] [Abstract][Full Text] [Related]
12. T-cell response of advanced aids patients after highly active antiretroviral therapy.
Wang AX; Li TS; Cao YZ; Han Y; Qiu ZF; Xie J
Chin Med Sci J; 2005 Dec; 20(4):223-5. PubMed ID: 16422247
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus and the gastrointestinal immune system: does highly active antiretroviral therapy restore gut immunity?
Costiniuk CT; Angel JB
Mucosal Immunol; 2012 Nov; 5(6):596-604. PubMed ID: 22929559
[TBL] [Abstract][Full Text] [Related]
14. Normalized CD8+ but not CD4+ lymphocyte IL-2 expression is associated with early treatment with highly active antiretroviral therapy.
Akerele T; Galatowicz G; Bunce C; Calder V; Lynn WA; Lightman S
Clin Immunol; 2006 Nov; 121(2):191-7. PubMed ID: 16987710
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and risk factors of poor immune recovery among adult HIV patients attending care and treatment centre in northwestern Tanzania following the use of highly active antiretroviral therapy: a retrospective study.
Gunda DW; Kilonzo SB; Kamugisha E; Rauya EZ; Mpondo BC
BMC Res Notes; 2017 Jun; 10(1):197. PubMed ID: 28595630
[TBL] [Abstract][Full Text] [Related]
16. Immunopathology of the duodenal mucosa of HIV-positive patients during combined antiretroviral therapy.
Machado FR; Pagliari C; Caiafa H; Tapajós R; Duarte MI
Braz J Med Biol Res; 2006 Jan; 39(1):107-17. PubMed ID: 16400471
[TBL] [Abstract][Full Text] [Related]
17. Mucosal plasma cell repertoire during HIV-1 infection.
Scamurra RW; Nelson DB; Lin XM; Miller DJ; Silverman GJ; Kappel T; Thurn JR; Lorenz E; Kulkarni-Narla A; Janoff EN
J Immunol; 2002 Oct; 169(7):4008-16. PubMed ID: 12244203
[TBL] [Abstract][Full Text] [Related]
18. Effect of maintaining highly active antiretroviral therapy on AIDS events among patients with late-stage HIV infection and inadequate response to therapy.
Gandhi T; Wei W; Amin K; Kazanjian P
Clin Infect Dis; 2006 Mar; 42(6):878-84. PubMed ID: 16477568
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of T-cell subsets and their relationship with oral and systemic opportunistic infections in HIV/AIDS patients during the first year of HAART in Guangxi, China.
Zhang L; Huang Y; Liu Z; Liu W; Qin Q; Tao R
J Med Virol; 2015 Jul; 87(7):1158-67. PubMed ID: 25777553
[TBL] [Abstract][Full Text] [Related]
20. Subclass composition and J-chain expression of the 'compensatory' gastrointestinal IgG cell population in selective IgA deficiency.
Nilssen DE; Brandtzaeg P; Frøland SS; Fausa O
Clin Exp Immunol; 1992 Feb; 87(2):237-45. PubMed ID: 1735187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
